Related Experiment Video
Updated: Jun 23, 2025

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Mendelian randomization supports causality between COVID-19 and glaucoma
Maolin Chen1,2, Yinhui Zhang1,2, Yu Yao3
1Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Insights
This study suggests a potential causal link between Corona Virus Disease 2019 (COVID-19) and an increased risk of glaucoma. Mendelian randomization analysis found significant associations between COVID-19 and glaucoma development.
Area of Science:
- Ophthalmology
- Genetics
- Epidemiology
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- The potential impact of Corona Virus Disease 2019 (COVID-19) on glaucoma risk remains unclear.
- Understanding genetic predispositions and disease interactions is crucial for public health.
Purpose of the Study:
- To investigate a potential causal relationship between COVID-19 and glaucoma.
- To apply a robust genetic epidemiology method to assess this association.
- To provide evidence for future clinical and public health strategies.
Main Methods:
- A two-sample Mendelian randomization (MR) design was employed.
- Inverse-variance-weighted (IVW) analysis was the primary statistical method.
- Genome-Wide Association Study (GWAS) data from the IEU database was utilized, with sensitivity analyses including heterogeneity, pleiotropy, and leave-one-out tests.
Main Results:
- Significant associations were observed between COVID-19 (release) and increased glaucoma risk (ORs ranging from 1.164 to 1.227, P < 0.05).
- COVID-19 hospitalizations also showed a significant association with elevated glaucoma risk (ORs ranging from 1.097 to 1.156, P < 0.05).
- Sensitivity analyses confirmed the robustness and reliability of the findings (P > 0.05).
Conclusions:
- This Mendelian randomization study provides preliminary evidence supporting a causal link between COVID-19 and an increased risk of developing glaucoma.
- Further research is warranted to elucidate the underlying biological mechanisms.
- These findings may inform preventative measures and clinical management for individuals at risk.
Abstract:
To determine whether there is a causal relationship between Corona Virus Disease 2019 (COVID-19) and glaucoma, a 2-sample Mendelian Randomization (MR) design was applied with the main analysis method of inverse-variance-weighted. The reliability of the results was checked using the heterogeneity test, pleiotropy test, and leave-one-out method. Four sets of instrumental variables (IVs) were used to investigate the causality between COVID-19 and glaucoma risk according to data from the IEU Genome Wide Association Study (GWAS). The results showed that 2 sets of COVID-19(RELEASE) were significantly associated with the risk of glaucoma [ID: ebi-a-GCST011071, OR (95% CI) = 1.227 (1.076-1.400), P = .002259; ID: ebi-a-GCST011073: OR (95% CI) = 1.164 (1.022-1.327), P = .022450; 2 sets of COVID-19 hospitalizations were significantly associated with the risk of glaucoma (ID: ebi-a-GCST011081, OR (95% CI) = 1.156 (1.033-1.292), P = .011342; ID: ebi-a-GCST011082: OR (95% CI) = 1.097 (1.007-1.196), P = .034908)]. The sensitivity of the results was acceptable (P > .05) for the 3 test methods. In conclusion, this MR analysis provides preliminary evidence of a potential causal relationship between COVID-19 and glaucoma.
Related Concept Videos
Genetic Lingo
Single Nucleotide Polymorphisms-SNPs
Causality in Epidemiology
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Glaucoma: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

